Abnormal copper and tryptophan metabolism and chelation therapy in anticonvulsant drug intolerance.
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D002614:Chelating Agents / Q000627:therapeutic use*; D003300:Copper / Q000378:metabolism*; D004492:Edetic Acid / Q000627:therapeutic use*; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D011164:Porphyrias / Q000209:etiology*; D014364:Tryptophan / Q000378:metabolism*; D026681:Vitamin B 6 Deficiency / Q000209:etiology*
D000927:Anticonvulsants; D002614:Chelating Agents; D003300:Copper; D014364:Tryptophan; D004492:Edetic Acid